本网站涉及的有关益生菌对人体健康影响的公开科学数据、文章及任何内容，均为针对益生菌本身已经科学验证的数据，非我公司产品之宣传。我公司产品不用于诊断、治疗、或预防任何疾病。
1. 使用快速、有效的共同培养模式来评估商业可购的乳酸杆菌菌株之抗发炎及屏障强化能力。
Use of a fast and efficient co-culture model to evaluate anti-inflammatory and barrier-reinforcing effects of commercial Lactobacillus strains. The 6th Congress of Asian Society for Pediatric Research & 51st Annual Meeting Of Taiwan Pediatric Association, April 15-18, 2010.
2. 评估鼠李糖乳杆菌作为附加疗法治疗多年生过敏性鼻炎儿童（7-12岁）的有效性和安全性：一个为期8周、随访4周、双盲、随机的安慰剂对照研究。
Evaluation of Efficacy and Safety of Lactobacillus rhamnosus as an Add-on Therapy in Children(7-12 Years Old) with Perennial Allergic Rhinitis: An 8 Weeks, Double-blind, Randomized, Placebo-controlled Study with a 4-week Follow-up. ISSN 1608-8115 ACTA PAEDIATRICA TAIWANICA, November 2012, Vol. 53, Supplement.
3. 评估鼠李糖乳杆菌在4个月到4岁异位性皮肤炎的病童的有效性及安全性：一个为期8周、双盲、随机的安慰剂对照研究。
Evaluation of Efficacy and Safety of Lactobacillus rhamnosus in Children Aged 4-48 Months with Atopic Dermatitis: A 8-Week, Double-Blind, Randomized, Placebo-Controlled Study. 2013 台湾儿科医学会 第二一四届学术演讲会 – 44
4. 双歧杆菌与鼠李糖乳杆菌三联活菌制剂联合治疗小儿轮状病毒肠炎的疗效及对免疫功能的影响。
Clinical effects for patients with rotaviral enteritis by Bifidobacterium combined with Lactobacillus rhamnosus and the influence on the immune function. Medical Innovation of China 2016 Vol.13, No.6 p.59-61.
5. 补充双歧杆菌与鼠李糖乳杆菌三联活菌制剂对肠道手术后肠道菌群的影响。
Effects of supplemented Bifidobacterium and Lactobacillus acidophilus triple living bacteria preparation on intestinal flora after intestinal surgery. CHINA MODERN MEDICINE Vol. 24 No. 5 February 2017.
6. 活性益生菌治疗过敏性鼻炎的临床观察及免疫调节作用分析。
Clinical observation of active probiotics in the treatment of allergic rhinitis and analysis of its effect on immunoregulation. CHINA MODERN DOCTOR Vol. 55 No. 5 February 2017.
7. 鼠李糖乳杆菌对4-48个月异位性皮肤炎孩童的疗效和安全性评估。
Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study. Journal of Microbiology, Immunology and Infection. Volume 50, Issue 5, October 2017, p. 684-692
8. 婴儿早期应用乳酸杆菌四联菌对预防过敏性疾病的临床研究。
A clinical study on early application of lactobacillus tetravaccine in preventing allergic diseases of infants. Practical Journal of Clinical Medicine Vol.15 No.4 July 2018.
9. 鼠李糖乳杆菌MP108之安全性评估。
Lactobacillus rhamnosus MP108: Toxicological evaluation. J Food Sci. 2021 Jan;86(1):228-241
1. Lactobacillus paracaseiET-22 Suppresses Dental Caries by Regulating Microbiota ofDental Plaques and Inhibiting Biofilm Formation。
2. Postbiotics Derived from L. paracasei ET-22 |nhibit the Formation of S. mutansBiofilms and Bioactive Substances: An Analysis
3. Lactobacillus paracasei ET-22 and derived postbiotics reduce halitosis and modulateoral microbiome dysregulation -a randomized, double-blind placebo-controlledclinical trial
4.副干酪乳杆菌ET-22对金黄地鼠口腔溃疡的预防作用及机制
5.益生菌对断奶鼠消化酶活力、肠道运动性及粘膜形态的影响
1. Effect of different doses of Lacticaseibacillus paracasei K56 on body fat andmetabolic parameters in adult individuals with obesity: a pilot study
2. Differential Modulation ofthe Metabolic Effects of Diet-Induced Obesity byProbiotic Lactobacillus ParacaseiK56 and Prebiotic a-Galactooligosaccharides
3. Effects of Coix seed extract, Lactobacillus paracasei K56, and their combinationon the glycolipid metabolism in obese mice
4.副干酪乳杆菌K56 调节肠道菌群及润肠通便功能研究
SCI期刊1 (IF:3.9)：Heat-killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward to Th1 polarization.
SCI期刊2 (IF:3.1)：Bacteriostatic activities of lactic acid bacteria against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli.
SCI期刊3 (IF:3.1)：Bacteriostatic abilities of viable and heat-killed lactic acid bacteria against group B Streptococcus.
SCI期刊4 (IF:3.1)：Assessment of bacteriostatic activities of viable and non-viable lactic acid bacteria against methicllin-resistant Staphylococcus aureus.
SCI期刊5 (IF:2.4)：Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens.
SCI期刊6 (IF:3.7)：Multi-strain probiotic supplement attenuates streptozotocin-induced type-2 diabetes by reducing inflammation and β-cell death in rats.
SCI期刊7 (IF:2.6)：Viable and Heat‑Killed Probiotic Strains Improve Oral Immunity by Elevating the IgA Concentration in the Oral Mucosa.
SCI期刊8 (IF:5.9)：A Combined Supplement of Probiotic Strains AP-32, bv-77, and CP-9 Increased Akkermansia mucinphila and Reduced Non-Esterified Fatty Acids and Energy Metabolism in HFD-Induced Obese Rats.
SCI期刊9 (IF:5.2)：Adjuvant probiotics of lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and bifidobacterium animalis subsp. lactis CP-9 attenuate glycemic levels and in flammatory cytokines in patients with type 1 diabetes mellitus.
SCI期刊10 (IF:3.9)：Safety and the probiotic potential of Bifidobacterium animalis CP-9.
SCI期刊11 (IF:5.0)：A multi-strain probiotic blend reshaped obesity-related gut dysbiosis and improved lipid metabolism in obese children.
SCI期刊12 (IF:1.6)：Adjuvant probiotic Bifidobacterium animalis subsp. lactis CP-9 improve phototherapeutic treatment outcomes in neonatal jaundice among full-term newborns: A randomized double-blind clinical study.
SCI期刊13 (IF:5.9)：A Three-Arm, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Lactobacillus salivarius AP-32 and Bifidobacterium animalis CP-9 Used Individually in Healthy Infants.
中文核心期刊1 (IF:0.08)：动物双歧杆菌CP-9对犬肠道菌群及粪便化学性状的影响.
Effect of Bifidobacterium animalis CP-9 on intestinal flora and fecal chemical traits in dogs
中文核心期刊2 (IF:0.33)：动物双歧杆菌CP-9联合干扰素ω对猫轮状病毒感染性肠炎的临床效果观察.
Observation on the clinical effect of Bifidobacterium animalis CP-9 combined with interferon ω on feline rotavirus infectious enteritis
中文核心期刊3 (IF:0.872)：动物双歧杆菌和罗伊氏乳杆菌改善肥胖小鼠糖脂代谢异常的研究
EFFECTS OF BIFIDOBACTERIUM CP-9 AND LACTOBACILLUS REUTERI ON GLUCOSE AND LIPID METABOLISM IN OBESE MICE
中文核心期刊4 (IF:0.206)：生态疗法对慢性便秘的疗效观察
Observation of the effect of microecological therapy on chronic constipation
